Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04060134 · ClinicalTrials.gov registry record
A Retrospective Breast Reconstruction Study
A clinical trial, sponsored by Elutia.
- Completed
- Registry status
- 223
- Enrollment target
NCT04060134 is a clinical trial that has completed, run by Elutia. The registered enrollment target is 223 participants.
The verdict
NCT04060134 has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 223 participants
- Enrollment target
Study Summary
To collect data on patients who have previously undergone breast reconstruction utilizing SimpliDerm and other HADMs.
Interventions
- OTHER SimpliDerm HADM
- OTHER AlloDerm HADM
- OTHER AlloMax HADM
- OTHER FlexHD HADM
- OTHER DermACELL HADM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2022-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04060134
The ClinicalTrials.gov registry entry for NCT04060134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elutia, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which SimpliDerm HADM is the first listed.
NCT04060134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04060134 about?
NCT04060134 is a clinical study titled "A Retrospective Breast Reconstruction Study". To collect data on patients who have previously undergone breast reconstruction utilizing SimpliDerm and other HADMs.
What is the current status of trial NCT04060134?
This trial is currently completed. The enrollment target is 223 participants. The study started on 2019-11-20. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT04060134?
The interventions under investigation include: SimpliDerm HADM (OTHER), AlloDerm HADM (OTHER), AlloMax HADM (OTHER), FlexHD HADM (OTHER), DermACELL HADM (OTHER).
Who is sponsoring clinical trial NCT04060134?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.